Anzeige
Mehr »
Login
Dienstag, 07.05.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
+56,25% in 5 Tagen: Genialer Schachzug - diese Übernahme verändert alles
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
131 Leser
Artikel bewerten:
(0)

Active-Investors: Wired News - German Court Rules in Favor of Aspen Aerogels in Patent Infringement Case; Issues Injunctions Against Hiltex

LONDON, UK / ACCESSWIRE / January 25, 2018 / Active-Investors.com has just released a free research report on Aspen Aerogels, Inc. (NYSE: ASPN). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/'symbol=ASPN as the Company's latest news hit the wire. On January 23, 2018, the Company announced that the Mannheim Regional Court in Germany had ruled in favor of the Company in the patent infringement lawsuit against Hiltex Techniche Weefsels B.V. ("Hiltex"). The Court also issued a series of judgments and related injunctions against Hiltex prohibiting it from reselling certain aerogel products manufactured in China. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Aspen Aerogels most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/'symbol=ASPN

Details of the Lawsuit and the Court's ruling

Aspen Aerogels had filed a lawsuit against Hiltex, which was reselling aerogel blankets, produced by Alison Hi-Tech Co. Ltd, against which the Company had claimed infringement of four European patents. The German Court's ruling came in after Hiltex backed the Company's claim. The Court issued a series of judgments and injunctions including the order to Hiltex to stop selling of Chinese manufactured aerogel products in Germany. The Court also determined that Hiltex is liable to Aspen Aerogels for damages. Following the Court's judgement, Aspen Aerogels and Hiltex reached a settlement according to which Hiltex has agreed to stop selling the contentious Chinese made aerogel blankets in any European country where the patents are applicable. Aspen Aerogels had also filed a lawsuit against Alison in the same German Court and the case is ongoing.

Commenting on the German Court's favorable ruling, Don Young, President and CEO of Aspen Aerogels, said:

"Our recent wins both in Germany and in the initial determination at the International Trade Commission serve to validate the strength of the patent portfolio protecting our aerogel technology platform. From the outset, we have maintained our firm belief that the sale, resale or use of Chinese aerogel products infringe our patents. Our core strategy is to invest in the research, development, commercialization, and protection of our aerogel technology platform worldwide. We remain firmly committed to defending our intellectual property and will continue to aggressively assert our rights against any Company that infringes our patented technology."

Backdrop

Earlier in October 2017, Aspen Aerogels had won the Initial Determination in International Trade Commission (ITC) Case against Alison Hi-Tech Co. Ltd and Nano Tech Co., Ltd, where Aspen Aerogels had claimed that Alison and Nano had infringed on its patents relating to aerogel insulation. The Initial Determination led by Administrative Law Judge McNamara of ITC found that Aspen Aerogels patent infringement claims were valid and confirmed that Alison and Nano had infringed on the said patents. Judge McNamara had suggested a limited exclusion order as a remedy to prevent the importation of infringing aerogel products into the US. The ITC is expected to make a final ruling on the matter by January 29, 2018, after final determination on the violation.

About Aspen Aerogels, Inc.

Northborough, Massachusetts-based Aspen Aerogels is a leading energy technology company providing innovative thermal management solutions for the energy insulation market. The Company designs, develops, and manufactures innovative, high-performance aerogel insulation used primarily in the energy infrastructure and building materials markets where thermal energy efficiency is at a premium and Aspen's products offer unique value. Aspen Aerogels' products offer insulations which is five times more effective than traditional insulation materials. Some of the Company's clients include companies in the Refining, Petrochemical, LNG, Power, and Subsea markets. The Company's main product brands include Cryogen®, Pyrogel®, and Spaceloft®, which are manufactured at its manufacturing facility located in East Providence, Rhode Island.

Stock Performance Snapshot

January 24, 2018 - At Wednesday's closing bell, Aspen Aerogels' stock marginally fell 0.93%, ending the trading session at $5.35.

Volume traded for the day: 77.89 thousand shares.

Stock performance in the last month - up 8.52%; previous three-month period - up 22.99%; past twelve-month period - up 17.07%; and year-to-date - up 9.63%

After yesterday's close, Aspen Aerogels' market cap was at $125.72 million.

The stock is part of the Industrial Goods sector, categorized under the General Building Materials industry. This sector was flat at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2018 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.